Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Girdhar G. Agarwal is active.

Publication


Featured researches published by Girdhar G. Agarwal.


BMC Health Services Research | 2009

Care-seeking behavior and out-of-pocket expenditure for sick newborns among urban poor in Lucknow, northern India: a prospective follow-up study

Neeraj Mohan Srivastava; Shally Awasthi; Girdhar G. Agarwal

BackgroundThe state of Uttar Pradesh, India accounts for one-quarter of Indias neonatal deaths and 8 percent of those worldwide. More than half (52%) of these deaths occur due to infections. In order to achieve Millennium Development Goal-4 of reducing child mortality by two-thirds by the year 2015, it is important to study factors which affect neonatal health. In Uttar Pradesh there is meager data for spending on health care in general and neonates in particular.MethodsThe study was conducted at an urban Reproductive and Child Health (RCH) center and a District hospital. Neonates were enrolled within 48 hours of birth and were followed-up once at 6 weeks ± 15 days at the OPD of the respective hospitals or at home. This study assessed (1) distribution of neonatal illnesses and different health providers sought (2) distribution of out-of-pocket expenditures by type of illness and type of health provider sought (3) socio-economic distribution of neonatal illnesses, care-seeking behavior and out-of-pocket expenditures. Per-protocol analysis was performed.ResultsFive hundred and ten neonates were enrolled and 481(94.4%) were followed-up. Parents of 50.3% (242/481) neonates reported at least one symptom of illness. Of these 22.3% (107/481) neonates had illnesses with at least one reported Integrated Management of Neonatal and Childhood Illnesses (IMNCI) danger sign. Among IMNCI illnesses, point prevalence of septicemia was 6.2% and pneumonia was 5.2% while among non-IMNCI illnesses point prevalence of upper respiratory infection was 9.5%, and diarrhea was 7%. Community based non-government dispensers (NGDs) were leading health providers (37.6%). Mean monthly income of families was 2804 Indian Rupees (INR) (range: 800 to 14000; n = 510), where US


PLOS ONE | 2008

Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial.

Shally Awasthi; Girdhar G. Agarwal; Sushil K. Kabra; Sunit Singhi; Madhuri Kulkarni; Vaishali More; Abhimanyu Niswade; Raj Mohan Pillai; Ravi Luke; Neeraj Mohan Srivastava; Saradha Suresh; Valsan Philip Verghese; P. Raghupathy; Rakesh Lodha; Stephen D. Walter

1 = 42 INR. Mean out-of-pocket expenditure on neonatal illness was 547.5 INR (range: 1 to 15000; n = 202) and mean out-of-pocket expenditure for hospitalization was 4993 INR (range: 41 to 15000; n = 17). All hospitalizations were for IMNCI illnesses. Neonates from lower income strata were less likely to receive any medical care (p < 0.0001) and were also less likely to be seen by a Government provider (p = 0.03).ConclusionSince more than half of the neonates have morbidity and out-of-pocket expenditure on neonatal illnesses often exceeds the family income of the lower strata of the low income group in the community, there is a need to either introduce health insurance scheme or subsidize health care for them. Also, since NGDs, half of which could be unqualified are leading health providers, qualified medical care-seeking for sick newborns should be promoted in urban Lucknow.


Cytokine | 2012

Association of TNF-α promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-α and leptin levels in Indian adult women.

Vani Gupta; Abhishek Kumar Gupta; Tabrez Jafar; Vandana Gupta; Suraksha Agrawal; Nidhi Srivastava; Sandeep Kumar; Arun Kumar Singh; Shankar Madhav Natu; C.G. Agarwal; Girdhar G. Agarwal

Background WHO-defined pneumonias, treated with antibiotics, are responsible for a significant proportion of childhood morbidity and mortality in the developing countries. Since substantial proportion pneumonias have a viral etiology, where children are more likely to present with wheeze, there is a concern that currently antibiotics are being over-prescribed for it. Hence the current trial was conducted with the objective to show the therapeutic equivalence of two treatments (placebo and amoxycillin) for children presenting with non-severe pneumonia with wheeze, who have persistent fast breathing after nebulisation with salbutamol, and have normal chest radiograph. Methodology This multi-centric, randomised placebo controlled double blind clinical trial intended to investigate equivalent efficacy of placebo and amoxicillin and was conducted in ambulatory care settings in eight government hospitals in India. Participants were children aged 2–59 months of age, who received either oral amoxycillin (31–54 mg/Kg/day, in three divided doses for three days) or placebo, and standard bronchodilator therapy. Primary outcome was clinical failure on or before day- 4. Principal Findings We randomized 836 cases in placebo and 835 in amoxycillin group. Clinical failures occurred in 201 (24.0%) on placebo and 166 (19.9%) on amoxycillin (risk difference 4.2% in favour of antibiotic, 95% CI: 0.2 to 8.1). Adherence for both placebo and amoxycillin was >96% and 98.9% subjects were followed up on day- 4. Clinical failure was associated with (i) placebo treatment (adjusted OR = 1.28, 95% CI: 1.01 to1.62), (ii) excess respiratory rate of >10 breaths per minute (adjusted OR = 1.51, 95% CI: 1.19, 1.92), (iii) vomiting at enrolment (adjusted OR = 1.49, 95% CI: 1.13, 1.96), (iv) history of use of broncho-dilators (adjusted OR = 1.71, 95% CI: 1.30, 2.24) and (v) non-adherence (adjusted OR = 8.06, 95% CI: 4.36, 14.92). Conclusions Treating children with non-severe pneumonia and wheeze with a placebo is not equivalent to treatment with oral amoxycillin. Trial Registration ClinicalTrials.gov NCT00407394


Journal of Tropical Pediatrics | 2008

Effectiveness of 3-Day Amoxycillin vs. 5-Day Co-trimoxazole in the Treatment of Non-severe Pneumonia in Children Aged 2-59 Months of Age: A Multi-centric Open Labeled Trial

Shally Awasthi; Girdhar G. Agarwal; Jai Veer Singh; S. K. Kabra; Raj Mohan Pillai; Sunit Singhi; Baridalyne Nongkynrih; Rashmi Dwivedi; Vaishali More; Madhuri Kulkarni; Abhimanyu Niswade; Bhavneet Bharti; Ankur Ambast; Puneet Dhasmana

BACKGROUND Tumour necrosis factor alpha is a multifunctional proinflammatory cytokine involved in the pathogenesis of metabolic syndrome, insulin resistance, and obesity. Aim of this study is to investigate in a North Indian female population the impact of the G-308A TNF-α variant on various components of the metabolic syndrome, Insulin Resistance, serum TNF-α and Leptin levels. METHODS The G-308A TNF-α polymorphism has been studied in 269 females with metabolic syndrome (NCEP ATP III criteria) (age 31.91±6.05) and 272 healthy females without metabolic syndrome (age 30.96±7.01). The G-308A variant was detected by PCR amplification and Nco-1 digestion. RESULTS Homozygous mutant genotype (AA) (p=<0.001: OR=3.24: 95% CI=2.15-4.89) and mutant allele (A) (p=<0.001: OR=3.04: 95% CI=2.08-4.43) of TNF-α was significantly less frequently observed in the control population as compared to study group. Furthermore, on dividing the subjects into two groups according to the absence (TNF-1 allele) or presence of the mutant A (TNF-2) allele, significant results were obtained in most of the metabolic risk factors. CONCLUSIONS Our results suggest that the G-308A polymorphism of the TNF-α gene may be independently associated with hypertension, leptin level and hypercholesterolemia leading to metabolic syndrome independent of Insulin resistance and hyperglycemia.


Tropical Medicine & International Health | 2009

Effect of behaviour change communication on qualified medical care-seeking for sick neonates among urban poor in Lucknow, Northern India: a before and after intervention study

Shally Awasthi; Neeraj Mohan Srivastava; Girdhar G. Agarwal; Shubha Pant; Tej P. Ahluwalia

This cluster randomized, open labeled trial was conducted to compare the effectiveness of 3 days of oral amoxycillin and 5 days of co-trimoxazole treatment in terms of clinical failure in children with World Health Organization (WHO) defined non-severe pneumonia in primary health centers in rural India. Participants were children aged 2-59 months with WHO defined non-severe pneumonia, with or without wheeze, who were accessible to follow up. From seven primary health centers in each arm, 2009 cases were randomized, 993 and 1016 in treatment with amoxycillin and co-trimoxazole, respectively. Fever was present in 1247 (62.1%) and wheeze in 443 (22.1%). There was good adherence and low loss to follow-up. Clinical failure on amoxycillin and co-trimoxazole on intention to treat analysis was 137 and 97, respectively (absolute difference = 0.04, 95% confidence interval: - 0.035-0.12). We conclude that there was no difference in effectiveness of oral co-trimoxazole or amoxycillin in treating non-severe pneumonia.


Journal of Paediatrics and Child Health | 2009

Four-country surveillance of intestinal intussusception and diarrhoea in children.

Shally Awasthi; Girdhar G. Agarwal; Vikas Mishra; Vijay Laxmi Nag; Hesham El Sayed; Antonio Jose Ledo Da Cunha; Alvaro Madeiro; Dipty Jain; William Macharia; James Ndung'u; Saumya Awasthi; Ashish Wakhlu

Objective  To assess the impact of a behaviour change communication (BCC) intervention on qualified medical care‐seeking for sick newborns in urban Lucknow, northern India.


Indian Journal of Pediatrics | 2009

Serum Homocysteine in Indian Adolescents

Pratima Anand; Shally Awasthi; Abbas Ali Mahdi; Manoj Tiwari; Girdhar G. Agarwal

Aim:  Establishment of baseline epidemiology of intussusception in developing countries has become a necessity with the possibility of reintroduction of rotavirus vaccine. The current study assessed the seasonal trend in cases admitted with intussusceptions and dehydrating acute watery diarrhoea in children aged 2 months to 10 years.


Current Medical Research and Opinion | 2007

Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.

Siddharth Kumar Das; Anil Pareek; D. S. Mathur; Ajay Wanchu; Ragini Srivastava; Girdhar G. Agarwal; R. S. Chauhan

ObjectiveTo assess serum homocysteine levels and its association with conventional risk factors for cardiovascular disease (CVD) in Indian adolescents.MethodsThis was a cross-sectional study conducted in tertiary care hospital in northern India in apparently healthy adolescents aged 10–19 yr. A pre-designed questionnaire was used to assess conventional risk factors. Serum homocysteine levels of ≥ 12μmol/L, serum triglycerides ≥ 150 mg% and serum cholesterol ≥ 200 mg% were taken as hyperhomocysteinemia, hypertriglyceridemia and hypercholesterolemia, respectively. Serum high-density lipoprotein (HDL) ≥ 40 mg% was considered protective for CVD.ResultsIn 103 subjects, 36.87 % females, mean serum homocysteine level was 11.649 ±0.416μmol/L. Hyperhomocysteinemia was present in 46 (44.6%, 95% CI: 34.965–54.75) subjects. Dietary deficiency of vitamin B12 and folic acid, body mass index (BMI) > 84th percentile and altered lipid profile were associated with hyperhomocysteinemia on univariate analysis. After multivariate adjustment for BMI and vegetarian diet, low serum HDL (OR: 23.81, 95% CI: 2.86–200; p =0.003) and serum hypertriglyceridemia (OR: 4.17, 95% CI: 1.51–13.51; p = 0.022) had independent association with hyperhomocysteinemia.ConclusionSince we have also found an association between hyperhomocysteinemia and low serum HDL levels and hypertriglyceridemia, which are conventional risk factors for CVD, interventional strategies are urgently needed among adolescents for prevention of CVD.


Communications in Statistics-theory and Methods | 2002

LINEAR FUNCTIONS OF UNIFORM ORDER STATISTICS AND B-SPLINES

Girdhar G. Agarwal; Rohan J. Dalpatadu; Ashok K. Singh

ABSTRACT Objective: Hydroxychloroquine (HCQ) has been used for a long time worldwide as a therapy for rheumatoid arthritis (RA). This trial was designed to determine whether HCQ was efficacious and safe in Indian patients with RA. Research design and methods: The trial was a multicentre, placebo controlled, randomized and double-blind study. One hundred and twenty-two patients with RA were enrolled in 3 different centres for the trial (26 males and 96 females in the age group of 18–60 years). Patients were randomized to receive either hydroxychloroquine tablets (n = 61) two tablets of 200 mg daily or placebo (n = 61) two tablets daily. After 8 weeks all patients received one tablet of hydroxychloroquine 200 mg daily for 4 weeks. Every patient also received one tablet of Nimesulide 100 mg twice daily. Main outcome measures: Assessment of response at 12 weeks using modified ACR 20 (American College of Rheumatology 20) criteria where Health Assessment Questionnaire (HAQ) was replaced by ARA (American Rheumatology Association) functional class. Results: 40.4% of patients on hydroxychloroquine showed improvement by modified ACR response criteria whereas only 20.7% ( p = 0.02) showed improvement in the placebo group. No significant side effects were observed in any of the patients. There were no ocular toxicities. Conclusions: Hydroxychloroquine was found to be an effective and well-tolerated drug in rheumatoid arthritis in Indian patients.


Developmental Medicine & Child Neurology | 2013

Prevalence and risk factors for neurological disorders in children aged 6 months to 2 years in northern India.

Anupama Bhave; Roli Bhargava; Girdhar G. Agarwal

ABSTRACT The purpose of the present paper is to give a simplified method of finding the density function and the moments of linear function of order statistics from uniform distribution. This is done by using a relationship between a B-spline and the linear function of uniform order statistics. Two examples are presented to illustrate this method. Some applications of the results are also considered.

Collaboration


Dive into the Girdhar G. Agarwal's collaboration.

Top Co-Authors

Avatar

Siddharth Kumar Das

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Ragini Srivastava

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Shally Awasthi

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Puneet Kumar

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

S.K. Agarwal

National Physical Laboratory

View shared research outputs
Top Co-Authors

Avatar

Anupama Bhave

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Divya Mehrotra

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Nuzhat Husain

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Ragini Singh

King George's Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge